Breaking News

BioCina, GPN Vaccines Expand Pneumococcal Vax Mfg. Pact

BioCina will manufacture large-scale cGMP batches of pneumococcal vaccine from its facility in Adelaide, Australia.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BioCina Pty Ltd., a global biologics CDMO, expanded its partnership with GPN Vaccines Ltd., a biotechnology company developing an engineered whole-cell vaccine called Gamma-PN against Streptococcus pneumoniae. This bacterium is responsible for causing life-threatening infections such as pneumonia, bacteremia, and meningitis. GPN’s vaccine technology is an engineered strain of Streptococcus pneumoniae that lacks capsular polysaccharide and expresses surface proteins common to all serotypes,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters